ZimVie Announces FDA Clearance and U.S. Launch of GenTek® Restorative Components Addition of Premium Restorative Components Enhances ZimVie's End-to-End Implant Offerings Addition of Premium Restorative Components Enhances ZimVie's End-to-End Implant Offerings
ZimVie to Report Second Quarter Financial Results on August 1, 2024 PALM BEACH GARDENS, Fla., July 18, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced it will report financial results for the second quarter 2024 after market close on Thursday, August 1, 2024. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time.
ZimVie: Guidance Suggests Company Fairly Valued At The Moment (Rating Downgrade) ZimVie''s margin of error in turning around the dental business remains small, as the remaining debt load remains substantial. See why ZIMV stock is a Hold.
ZimVie to Participate in Upcoming Investor Conferences PALM BEACH GARDENS, Fla., May 16, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced that the company will be participating in two upcoming investor conferences.
ZimVie to Participate in Upcoming Investor Conferences PALM BEACH GARDENS, Fla., May 16, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced that the company will be participating in two upcoming investor conferences.
ZimVie Inc. (ZIMV) Q1 2024 Earnings Call Transcript ZimVie Inc. (NASDAQ:NASDAQ:ZIMV) Q1 2024 Earnings Conference Call May 8, 2024 4:30 PM ETCompany ParticipantsMarissa Bych - IR, Gilmartin Group LLCVafa…
ZimVie Inc. (ZIMV) Q1 2024 Earnings Call Transcript ZimVie Inc. (NASDAQ:ZIMV ) Q1 2024 Earnings Conference Call May 8, 2024 4:30 PM ET Company Participants Marissa Bych - IR, Gilmartin Group LLC Vafa Jamali - President and CEO Richard Heppenstall - CFO Conference Call Participants Matt Miksic - Barclays Operator Good afternoon and welcome to ZimVie's First Quarter 2024 Earnings Conference Call. Currently, all participants are in a listen-only mode.
ZIMV Stock Earnings: ZimVie Beats EPS, Beats Revenue for Q1 2024 ZimVie (NASDAQ: ZIMV ) just reported results for the first quarter of 2024. ZimVie reported earnings per share of 8 cents. This was above the analyst estimate for EPS of -4 cents. The company reported revenue of $118.20 million. This was 1.72% better than the analyst estimate for revenue of $116.20 million. InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com. More From InvestorPlace The #1 AI Investment Might Be This Company You’ve Never Heard Of Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In. Legendary Investor Predicts: “Forget A.I.
ZimVie to Report First Quarter Financial Results on May 8, 2024 PALM BEACH GARDENS, Fla., April 24, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced it will report financial results for the first quarter 2024 after market close on Wednesday, May 8, 2024. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time.